ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
Dow Jones
40.954,48
1,85%
Euro vs US Dollar
1,09018
0,02%
Bitcoin
65.102,34
0,39%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AstraZeneca PLC (AZN)

  7. AstraZeneca PLC (AZN) News

AZN

AstraZeneca (AZN)

AstraZeneca PLC
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AZN
DatumZeitQuelleÜberschriftSymbolFirma
24/10/202000h18Dow Jones NewsPivotal Studies of Covid-19 Vaccines From AstraZeneca, J&J Resuming -- 3rd UpdateNASDAQ:AZNAstraZeneca PLC
23/10/202022h41Dow Jones NewsCovid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S. -- 2nd UpdateNASDAQ:AZNAstraZeneca PLC
23/10/202020h56Dow Jones NewsCovid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S. -- UpdateNASDAQ:AZNAstraZeneca PLC
23/10/202014h00Dow Jones NewsInnate Pharma Gets $50 Million Milestone Payment From AstraZenecaNASDAQ:AZNAstraZeneca PLC
23/10/202007h00GlobeNewswire Inc.First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers $50M Payment From AstraZenecaNASDAQ:AZNAstraZeneca PLC
22/10/202011h59Dow Jones NewsCovid-19 Vaccine Makers to Face Challenges When Recognizing RevenueNASDAQ:AZNAstraZeneca PLC
21/10/202022h55Dow Jones NewsVolunteer in AstraZeneca/Oxford Coronavirus Vaccine Trial Dies in Brazil -- UpdateNASDAQ:AZNAstraZeneca PLC
21/10/202021h25Dow Jones NewsVolunteer in AstraZeneca/Oxford Coronavirus Vaccine Trial Dies in BrazilNASDAQ:AZNAstraZeneca PLC
20/10/202013h21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
20/10/202008h53Dow Jones NewsAstraZeneca Granted US Priority Review for Early-Stage Lung Cancer Adjuvant DrugNASDAQ:AZNAstraZeneca PLC
19/10/202013h21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
14/10/202013h00GlobeNewswire Inc.FibroGen to Present New Efficacy and Safety Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology...NASDAQ:AZNAstraZeneca PLC
13/10/202019h15Dow Jones NewsMexico Signs Agreements to Buy Potential Covid-19 VaccinesNASDAQ:AZNAstraZeneca PLC
13/10/202013h36Dow Jones NewsU.S. Stock Futures Wobble as Earnings Season BeginsNASDAQ:AZNAstraZeneca PLC
13/10/202013h08Dow Jones NewsU.S. Stock Futures Wobble as Earnings Season BeginsNASDAQ:AZNAstraZeneca PLC
13/10/202012h51Dow Jones NewsU.S. Stock Futures Wobble as Earnings Season BeginsNASDAQ:AZNAstraZeneca PLC
13/10/202012h26Dow Jones NewsU.S. Stock Futures Slip After J&J's Vaccine Trial Hits SnagNASDAQ:AZNAstraZeneca PLC
13/10/202011h46Dow Jones NewsU.S. Stock Futures Slip After J&J's Vaccine Trial Hits SnagNASDAQ:AZNAstraZeneca PLC
12/10/202008h48Dow Jones NewsAstraZeneca Gets $486 Million From US Government to Fund Covid-19 ResearchNASDAQ:AZNAstraZeneca PLC
08/10/202015h29Dow Jones NewsCovid-19 Vaccine-Trial Volunteers Look to Make a DifferenceNASDAQ:AZNAstraZeneca PLC
02/10/202008h41Dow Jones NewsAstraZeneca Gets Breakthrough Therapy Designation for Chronic Kidney Disease DrugNASDAQ:AZNAstraZeneca PLC
01/10/202017h06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AZNAstraZeneca PLC
29/09/202023h13Dow Jones NewsADRs Fall In New York Trading; AstraZeneca ADRs GainNASDAQ:AZNAstraZeneca PLC
29/09/202021h42Dow Jones NewsDanger Is Approaching for Coronavirus Vaccine Stocks -- Heard on the StreetNASDAQ:AZNAstraZeneca PLC
25/09/202013h01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AZNAstraZeneca PLC
26/10/201613h15GlobeNewswire Inc.Myriad’s BRACAnalysis CDx® Test Identifies Patients with Ovarian Cancer Who Would Benefit from Second-Line Maintenance Tre...NASDAQ:AZNAstraZeneca PLC
30/05/201301h01PR Newswire (US)Adult Patients in England and Wales to Gain Access to First-in-Class Type 2 Diabetes TreatmentNYSE:AZNBristol-Myers Squibb & AstraZeneca
29/10/201213h00PR Newswire (US)AstraZeneca Begins a New Global Study of FASLODEX® (Fulvestrant) 500 mg Injection in Patients With Hormone Receptor-Positive...NYSE:AZNAstraZeneca
22/08/201209h25Dow Jones NewsAstraZeneca Buys 250,000 Own Shares to CancelNYSE:AZN
16/02/201015h30PR Newswire (US)AstraZeneca Prescription Savings Programs Help More Patients in 2009NYSE:AZNN^CURN
 Showing the most relevant articles for your search:NASDAQ:AZN

Kürzlich von Ihnen besucht

BIT
UC27RZ
Unicredit Bank
NASDAQ
SABR
Sabre
BOV
CRVD5L
DON CAROLINA PNA PNA
KUCN
UOSBTC
Ultra Token
COIN
VAULTZUSD
VAULTZ
TSXV
JDR.P
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten